The American Brain Tumor Association is proud to join with other national patient advocacy organizations in supporting numerous worthwhile initiatives aimed at helping individuals with brain tumors and other diseases.
• Recently, we applauded the House Appropriations Committees’ inclusion of a much-needed increase in funding granted to the National Institutes of Health (NIH) in its draft FY12 Labor, Health and Human Services, Education, and Related Agencies funding bill. NIH funding vital to the millions of Americans hoping for breakthroughs in medical research.
• We also encouraged the Congressional Joint Select Committee on Deficit Reduction to protect funding for Medicare Part D—which is beneficial to millions of Americans who rely on its provisions for essential medications—as they look for ways in which to trim federal spending.
• Finally, we encouraged the Committee on Health, Education, Labor and Pensions to re-examine conflict of interest provisions on Special Government Employees serving on Food and Drug Administration (FDA) Advisory Committees, in order to ensure that such rules do not unnecessarily deprive the FDA of the expertise of the most well-informed researchers, clinicians and patients, especially in the area of rare diseases, where the potential pool of qualified individuals is already limited.
• Recently, we applauded the House Appropriations Committees’ inclusion of a much-needed increase in funding granted to the National Institutes of Health (NIH) in its draft FY12 Labor, Health and Human Services, Education, and Related Agencies funding bill. NIH funding vital to the millions of Americans hoping for breakthroughs in medical research.
• We also encouraged the Congressional Joint Select Committee on Deficit Reduction to protect funding for Medicare Part D—which is beneficial to millions of Americans who rely on its provisions for essential medications—as they look for ways in which to trim federal spending.
• Finally, we encouraged the Committee on Health, Education, Labor and Pensions to re-examine conflict of interest provisions on Special Government Employees serving on Food and Drug Administration (FDA) Advisory Committees, in order to ensure that such rules do not unnecessarily deprive the FDA of the expertise of the most well-informed researchers, clinicians and patients, especially in the area of rare diseases, where the potential pool of qualified individuals is already limited.
ليست هناك تعليقات:
إرسال تعليق